LEED M TABLET is used in the management of signs and symptoms of allergic rhinitis (sneezing, runny or stuffy nose, nasal itching, red, watery or itchy eyes, throat irritation, cough, headache and tiredness), chronic idiopathic urticaria (allergic skin reaction with red raised itchy bumps on skin) and bronchial asthma.
It contains a combination of two medicines namely, Levocetirizine and Montelukast which effectively reduces the allergic reactions triggered in your body. Take LEED M TABLET under medical supervision. Usually, it is prescribed for 14-15 days or for more duration based on your health condition. Follow the dosing schedule appropriately to effectively control the triggers to allergic responses.
Avoid consumption of alcohol while taking this medicine as it could make you feel drowsier. Before taking this medicine, inform your doctor if you have kidney problems, history of asthma, pregnant or breastfeeding as a precaution. It is ideal for use in adults and adolescents (aged 15 years or older).
The most common side effects of taking LEED M TABLET are upper respiratory tract infection, fever, cough, inflammation of the pharynx, dryness of mouth, headache and sleepiness. Talk to your doctor if any of these side effects trouble you.
It is used in the management of signs and symptoms associated with:
LEED M TABLET contains two medicines namely, levocetirizine and montelukast.
Together, this combination provides relief from allergy symptoms while also controlling asthma attacks and reducing inflammation in the airways.
Stop taking this medicine and contact doctor immediately if you experience any of the following side effects:
Before taking LEED M TABLET, inform your doctor if you are pregnant or think you may be pregnant as a precaution.
It is not known whether the combination of levocetirizine and Montelukast can pass through breast milk. Therefore, this medicine should be used with caution in breastfeeding women.
Do not drive or operate any machines if you experience sleepiness/drowsiness, fatigue or physical weakness.
Avoid consumption of alcohol while taking LEED M TABLET as it could cause reduction in alertness and impairment of performance.
LEED M TABLET is not recommended for use in patients with severe kidney impairment. It should be taken with extreme caution in patients with kidney disease.
LEED M TABLET should be taken with caution in patients with liver disease.
Do not take LEED M TABLET if you are allergic to Montelukast or Levocetirizine.
LEED M TABLET is not recommended for use in patients with asthma attacks.
LEED M TABLET can be used in adolescents (aged 15 years or older). For children aged below 15 years, you must consult your doctor for an optimum dosage.
LEED M TABLET should be used with caution in elderly patients (aged 65 years or above). Proper dose titrations and careful monitoring of kidney functions are required in such patients.
LEED M TABLET is not recommended for use if you:
Before taking LEED M TABLET, inform your physician if you:
A. Drug-Drug interactions:
Before taking LEED M TABLET, inform your doctor, if you are taking any of the following medicines:
Overdosage:
If you or anyone else take too much of LEED M TABLET, contact your doctor immediately or go to a hospital straight away. Overdosage symptoms of LEED M TABLET might include stomach pain, thirst, sleepiness, headache, vomiting, hyperactivity, agitation, excitation and restlessness.
Drug | : | Levocetirizine, Montelukast |
Pharmacological Category | : | H1 receptor antagonist, Leukotriene receptor antagonist |
Therapeutic Indication | : | Allergic rhinitis, Bronchial asthma, Chronic idiopathic urticaria |
Dosage Forms | : | Tablet, Capsule, Softgel capsule, Dispersible tablet, Syrup, Suspension |
To know more about this medicine:
A: Following oral administration with LEED M TABLET, it is believed to provide relief from the symptoms of allergy within 30 minutes to an hour.
A: No, it is only used to reduce the risk of having an asthma attack. It should not be used on an asthma attack that has been started already.
A: There is no proper research done on the safety and effectiveness of levocetirizine + montelukast combination in infants aged between 6-12 years of age. Therefore, consult your child’s doctor for the optimum dosage and duration of therapy.
A: Yes, LEED M TABLET may make you feel sleepy or drowsy. Try to rest and relax.
A: LEED M TABLET is not recommended for use in patients with severe kidney impairment. It should be taken with extreme caution in patients with kidney disease.
Levocetirizine+Montelukast TableT : Therapeutic Uses, Warning and Precautions, Interactions, Directions for Use, Side Effects and Storage
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.